These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7272419)

  • 1. A generalized multihit dose-response model for low-dose extrapolation.
    Rai K; Van Ryzin J
    Biometrics; 1981 Jun; 37(2):341-52. PubMed ID: 7272419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dose-response model incorporating nonlinear kinetics.
    Van Ryzin J; Rai K
    Biometrics; 1987 Mar; 43(1):95-105. PubMed ID: 3567309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dose-response model for teratological experiments involving quantal responses.
    Rai K; Van Ryzin J
    Biometrics; 1985 Mar; 41(1):1-9. PubMed ID: 4005367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of some methods for fitting dose-response models to quantal-response developmental toxicology data.
    Carr GJ; Portier CJ
    Biometrics; 1993 Sep; 49(3):779-91. PubMed ID: 8241373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A statistical test of compatibility of data sets to a common dose-response model.
    Stiteler WM; Knauf LA; Hertzberg RC; Schoeny RS
    Regul Toxicol Pharmacol; 1993 Dec; 18(3):392-402. PubMed ID: 8128001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporating additional biological phenomena into two-stage cancer models.
    Sielken RL; Bretzlaff RS; Stevenson DE
    Prog Clin Biol Res; 1994; 387():237-60. PubMed ID: 7972250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generalized Spearman estimators of relative dose.
    Morton R
    Biometrics; 1981 Jun; 37(2):223-33. PubMed ID: 7272411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bootstrap estimation of benchmark doses and confidence limits with clustered quantal data.
    Zhu Y; Wang T; Jelsovsky JZ
    Risk Anal; 2007 Apr; 27(2):447-65. PubMed ID: 17511711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Identification of a multihit model for nonhomogeneous cell population].
    Pavlova LV; Khanin LG; Iakovlev AIu
    Radiobiologiia; 1992; 32(6):785-7. PubMed ID: 1494644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A shared response model for clustered binary data in developmental toxicity studies.
    Pang Z; Kuk AY
    Biometrics; 2005 Dec; 61(4):1076-84. PubMed ID: 16401281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Threshold dose-response models in toxicology.
    Cox C
    Biometrics; 1987 Sep; 43(3):511-23. PubMed ID: 3663815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal design for dose response using beta distributed responses.
    Wu Y; Fedorov VV; Propert KJ
    J Biopharm Stat; 2005; 15(5):753-71. PubMed ID: 16078383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An improved procedure for low-dose carcinogenic risk assessment from animal data.
    Crump KS
    J Environ Pathol Toxicol Oncol; 1984 Jul; 5(4-5):339-48. PubMed ID: 6520736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On improved calibrations of unknowns in a system of quality-controlled assays.
    Hochberg Y; Marom I; Keret R; Peleg S
    Biometrics; 1983 Mar; 39(1):97-107. PubMed ID: 6871366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose-rate extrapolation using the multistage model.
    Portier C; Hoel D
    Biometrics; 1983 Dec; 39(4):897-906. PubMed ID: 6671125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mechanistic, predictive model of dose-response curves for cell cycle phase-specific and -nonspecific drugs.
    Gardner SN
    Cancer Res; 2000 Mar; 60(5):1417-25. PubMed ID: 10728708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interval estimation of inverse dose-response.
    Alho JM; Valtonen E
    Biometrics; 1995 Jun; 51(2):491-501. PubMed ID: 7662838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inclusion of biological factors in parallel-architecture normal-tissue complication probability model for radiation-induced liver disease.
    Cheng JC; Liu HS; Wu JK; Chung HW; Jan GJ
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1150-6. PubMed ID: 15990021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-incidence modeling: consequences of linking quantal measures of response to depletion of critical tissue targets.
    Andersen ME; Lutz RW; Liao KH; Lutz WK
    Toxicol Sci; 2006 Jan; 89(1):331-7. PubMed ID: 16237194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A parametric model for detecting hormetic effects in developmental toxicity studies.
    Hunt DL; Bowman D
    Risk Anal; 2004 Feb; 24(1):65-72. PubMed ID: 15028001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.